Role- State Sales Manager (Pharma (TGx)Experience - 7-10 yearsLocation - Surat/ MumbaiSalary - Up to 15 lpaMandatory Skills:- Experience in Pharma Sales.- Experience in Retail sales.- Experience with Distribution Network.- Candidates should...
- Develop a thorough understanding of our product offerings and target segment.- Prospect, qualify, follow up and educate a high volume of cold leads into prospects through outbound channels.- Servicing & qualifying inbound customer inquiri...
and Essential Duties India Collaborate with HR, GETI members & Line Managers to identify training needs of individual employee... with HR & respective Line Managers & explain the process to access LinkedIn Trainings from GetLearning platform. Monitor...
European natural gas prices fluctuated above €45 a megawatt-hour amid persistent supply concerns, with just a week left until a key transit deal between Russia and Ukraine expires. Continue Reading »
Pharma stocks to buy: Domestic brokerage Motilal Oswal has recommended Mankind Pharma, Lupin, Max Healthcare, IPCA Laboratories, and Piramal Pharma as the top pharma stocks on the radar for 2025 Continue Reading »
Wall Street Holiday: The US stock exchanges will remain closed on Wednesday, December 25, 2024 on account of Christmas celebrations across the globe. Continue Reading »
Steel Outlook 2025: For Tata Steel, JSW, JSPL, SAIL and other steel producers, India Government’s trade policies to check rising steel imports, and global growth outlook following Trump 2.0 remain the key themes that would drive domestic steel prices in CY2025, say experts Continue Reading »
As market expert CA Rudra Murthy of Vachana Investments predicts a potential 5-10% dip in the Nifty 50 during the first half of 2025, he highlights key sectors like pharmaceuticals and banking that may provide some solace amidst broader market challenges. Continue Reading »
Indian Stock Market: Multibagger SME stock Cellecor Gadget turns ₹1.10 lakh to ₹7.45 lakh in one year,. While the investors were made to invest ₹1,10,000 at the time of IPo, the iinvestements taking into consideration the stock split of 1:10 are now valued at ₹7,45,200 Continue Reading »